Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Methylpromazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.53 |
| ▸ | GFER | P55789 | 2/20 | 0.82 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.78 |
| ▸ | HTR1A | P08908 | 6/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 6/20 | 0.78 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.78 |
| ▸ | DRD3 | P35462 | 6/20 | 0.78 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.78 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.78 |
| ▸ | DRD1 | P21728 | 5/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.78 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.78 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.78 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.78 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.62 |
| ▸ | LMNA | P02545 | 5/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylpromazine SCHEMBL719590 | 0.90 | GFER (1.00) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| Methylpromazine SCHEMBL409663 | 0.90 | GFER (1.00) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| Methylpromazine SCHEMBL29354434 | 0.88 | CHRM2 (1.00) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| Methylpromazine SCHEMBL18994 | 0.88 | CHRM2 (1.00) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| Methylpromazine SCHEMBL18993 | 0.88 | CHRM2 (1.00) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| Methylpromazine SCHEMBL2774391 | 0.87 | CHRM2 (0.97) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| SCHEMBL21318406 | 0.83 | HTR1A (0.70) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| Levomepromazine SCHEMBL27701483 | 0.80 | LMNA (0.88) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| Levomepromazine SCHEMBL15789013 | 0.80 | CHRM2 (0.82) | GFERCHRM2HTR1ACHRM1ADRA1A | |
| Levomepromazine SCHEMBL15789014 | 0.80 | CHRM2 (0.82) | GFERCHRM2HTR1ACHRM1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210393645-A1 | TREATMENT FOR PROGRESSIVE MULTIPLE SCLEROSIS | UTI LIMITED PARTNERSHIP (CA) | 2021-12-23 | — | — | US | disclosed |
| US-20190262353-A1 | TREATMENT FOR PROGRESSIVE MULTIPLE SCLEROSIS | UTI LIMITED PARTNERSHIP (CA) | 2019-08-29 | — | — | US | disclosed |